UNIVERSITY OF CALIFORNIA SAN DIEGO

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private, Subsidiary

Established: 1960-11-18

Employees: 10K

Market Cap: -

Website: http://www.ucsd.edu

Clinical Trials

Study EvAluating Genotypes While Using Lucentis 2

Phase 4

Completed

Conditions: Age-Related Macular Degeneration

Interventions: Drug: Ranibizumab

First Posted Date: 2011-11-03

Last Posted Date: 2019-08-14

Lead Sponsor: University of California, San Diego

Target Recruit Count: 66

Registration Number: NCT01464723

Locations: 🇺🇸
Shiley Eye Center, University of California, San Diego, San Diego, California, United States

STudy to Assess Rapid Disease Progression by Clinical and Genetic Factors In Glaucoma patientS That Are High Risk

Completed

Conditions: Primary Open Angle Glaucoma

First Posted Date: 2011-09-29

Last Posted Date: 2024-01-23

Lead Sponsor: University of California, San Diego

Target Recruit Count: 133

Registration Number: NCT01442896

Locations: 🇺🇸
Hamilton Glaucoma Center, UCSD, La Jolla, California, United States

Implementation of Nucleic Acid Amplification Testing Screening to Identify Acute and Early HIV Infection

Not Applicable

Completed

Conditions: Acute HIV Infection

Interventions: Other: Nucleic Acid Amplification Testing

First Posted Date: 2011-09-15

Last Posted Date: 2019-10-21

Lead Sponsor: University of California, San Diego

Target Recruit Count: 22607

Registration Number: NCT01434706

Locations: 🇺🇸
Christie's Place, San Diego, California, United States
🇺🇸
San Diego LGBT Community Center, San Diego, California, United States
🇺🇸
UC San Diego Antiviral Research Center, San Diego, California, United States

and more 2 locations

Study in Healthy Adults to Determine the Effect That Food Has on the Absorption and Delivery of the Drug Cystagon™

Not Applicable

Completed

Conditions: Nephropathic Cystinosis
Cystinosis

Interventions: Drug: Cysteamine bitartrate

First Posted Date: 2011-09-13

Last Posted Date: 2013-10-09

Lead Sponsor: University of California, San Diego

Target Recruit Count: 8

Registration Number: NCT01432561

Locations: 🇺🇸
University of California, San Diego Center for Clinical Research Services (CCR), La Jolla, California, United States

Pharmacokinetics (PK)/Safety Study of Atorvastatin in Children With Kawasaki Disease and Coronary Artery Abnormalities

Phase 1

Completed

Conditions: Kawasaki Disease

Interventions: Drug: Atorvastatin

First Posted Date: 2011-09-09

Last Posted Date: 2020-05-06

Lead Sponsor: University of California, San Diego

Target Recruit Count: 34

Registration Number: NCT01431105

Locations: 🇺🇸
University of California San Diego, San Diego, California, United States

NAPLS Omega-3 Fatty Acid Versus Placebo Study

Phase 1

Completed

Conditions: Psychosis

Interventions: Drug: Placebo
Drug: Omega-3 Long Chain Fatty Acid

First Posted Date: 2011-09-07

Last Posted Date: 2021-02-25

Lead Sponsor: University of California, San Diego

Target Recruit Count: 127

Registration Number: NCT01429454

Locations: 🇺🇸
University of California, San Diego, San Diego, California, United States
🇺🇸
University of California, Los Angeles, Los Angeles, California, United States
🇺🇸
Emory University, Atlanta, Georgia, United States

and more 6 locations

Metabolism, Exercise and Nutrition at UCSD (MENU Study)

Not Applicable

Completed

Conditions: Obese
Nondiabetic

Interventions: Behavioral: Weight loss

First Posted Date: 2011-08-26

Last Posted Date: 2019-07-05

Lead Sponsor: University of California, San Diego

Target Recruit Count: 245

Registration Number: NCT01424007

Locations: 🇺🇸
Moores UCSD Cancer Center, La Jolla, California, United States

Ovarian Reserve Testing in Female Young Adult Cancer Survivors

Not Applicable

Active, not recruiting

Conditions: Cancer
Infertility

Interventions: Drug: recombinant FSH

First Posted Date: 2011-08-22

Last Posted Date: 2024-06-10

Lead Sponsor: University of California, San Diego

Target Recruit Count: 34

Registration Number: NCT01421095

Locations: 🇺🇸
UCSD Moores Cancer Center, San Diego, California, United States

Ranibizumab for the Management of Recurrent Nosebleeds in Patients With Hereditary Hemorrhagic Telangiectasia (HHT)

Phase 1

Withdrawn

Conditions: Hereditary Hemorrhagic Telangiectasia (HHT)
Nosebleeds

Interventions: Drug: Ranibizumab

First Posted Date: 2011-08-01

Last Posted Date: 2013-04-29

Lead Sponsor: University of California, San Diego

Registration Number: NCT01406639

Clinical Assessment Of Age-related Macular Degeneration Patients After Early Diagnosis and Treatment With Ranibizumab

Phase 2

Terminated

Conditions: Age-Related Macular Degeneration

Interventions: Drug: ranibizumab

First Posted Date: 2011-07-26

Last Posted Date: 2019-08-28

Lead Sponsor: University of California, San Diego

Target Recruit Count: 20

Registration Number: NCT01402544

Locations: 🇺🇸
California Retina Consultants, Santa Barbara, California, United States
🇺🇸
Shiley Eye Center, UCSD, La Jolla, California, United States
🇺🇸
Medical Center Ophthalmology Associates, San Antonio, Texas, United States

© Copyright 2025. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy